| Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and … J Schneider-Thoma, K Chalkou, C Dörries, I Bighelli, A Ceraso, M Huhn, ... The lancet 399 (10327), 824-836, 2022 | 160 | 2022 |
| A two‐stage prediction model for heterogeneous effects of treatments K Chalkou, E Steyerberg, M Egger, A Manca, F Pellegrini, G Salanti Statistics in medicine 40 (20), 4362-4375, 2021 | 22 | 2021 |
| Decision curve analysis for personalized treatment choice between multiple options K Chalkou, AJ Vickers, F Pellegrini, A Manca, G Salanti Medical Decision Making 43 (3), 337-349, 2023 | 14 | 2023 |
| Development, validation and clinical usefulness of a prognostic model for relapse in relapsing-remitting multiple sclerosis K Chalkou, E Steyerberg, P Bossuyt, S Subramaniam, P Benkert, J Kuhle, ... Diagnostic and prognostic research 5, 1-16, 2021 | 10 | 2021 |
| Synthesizing cross‐design evidence and cross‐format data using network meta‐regression T Hamza, K Chalkou, F Pellegrini, J Kuhle, P Benkert, J Lorscheider, ... Research Synthesis Methods 14 (2), 283-300, 2023 | 8 | 2023 |
| One-year outcomes after amulet or watchman device for percutaneous left atrial appendage closure: a prespecified analysis of the SWISS-APERO randomized clinical trial R Galea, N Meneveau, F De Marco, A Aminian, D Heg, K Chalkou, ... Circulation 149 (6), 484-486, 2024 | 5 | 2024 |
| Predicting the treatment response of certolizumab for individual adult patients with rheumatoid arthritis: protocol for an individual participant data meta-analysis Y Luo, K Chalkou, R Yamada, S Funada, G Salanti, TA Furukawa Systematic reviews 9, 1-8, 2020 | 4 | 2020 |
| Combining randomized and non‐randomized data to predict heterogeneous effects of competing treatments K Chalkou, T Hamza, P Benkert, J Kuhle, C Zecca, G Simoneau, ... Research synthesis methods, 2024 | 1 | 2024 |
| Explainable Artificial Intelligence to predict clinical outcomes in type 1 diabetes and relapsing-remitting multiple sclerosis adult patients A Ihalapathirana, K Chalkou, P Siirtola, S Tamminen, G Chandra, ... Informatics in Medicine Unlocked 42, 101349, 2023 | 1 | 2023 |
| Estimating Patient-Specific Relative Benefit of Adding Biologics to Conventional Rheumatoid Arthritis Treatment: An Individual Participant Data Meta-Analysis Y Luo, K Chalkou, S Funada, G Salanti, TA Furukawa JAMA Network Open 6 (6), e2321398-e2321398, 2023 | | 2023 |
| Real-world predictions of treatment effects using evidence synthesis for health technology assessment K Chalkou, G Salanti University of Bern, 2023 | | 2023 |
| Flexible generic framework for evidence synthesis in health technology T Hamza, F Pellegrini, J Kuhle, P Benkert, S Subramaniam, S Schaedelin, ... RCT 18, 22, 2021 | | 2021 |
| A Two-Stage Prediction Model for Heterogeneous Effects of Many Treatment Options: Application to Drugs for Multiple Sclerosis (1709) F Pellegrini, K Chalkou, C de Moor, S Belachew Neurology 96 (15_supplement), 1709, 2021 | | 2021 |
| NM2 Using Randomized and Observational DATA to Predict Heterogeneous Treatment Effects K Chalkou, F Pellegrini, G Salanti Value in Health 23, S406-S407, 2020 | | 2020 |
| Predicting the Treatment Response of Certolizumab for Individual Patients with Rheumatoid Arthritis: Protocol for An Individual Participant Data Meta-Analysis Y Luo, K Chalkou, R Yamada, S Funada, G Salanti, TA Furukawa | | 2020 |
| Cross-design and cross-data format synthesis using network meta-analysis T Hamza, F Pellegrini, J Kuhle, P Benkert, S Subramaniam, S Schaedelin, ... | | |
